The value of treatment choice and clinical prognosis for Riolan’s arch in chronic superior mesenteric artery ischaemic disease
International Journal of Colorectal Disease · 2024
DOI: 10.1007/s00384-024-04691-y ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2024. Verfasst von Mengqiang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, NO. 321 Zhongshan Road, Gulou District, Nanjing…. Hauptthemen laut MEDLINE: Mesenteric Artery, Superior. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific research project of Jiangsu Provincial Department of Health.
Abstract (Originalsprache)
Objective
To explore the value of treatment choice and clinical prognosis for Riolan’s arch in chronic superior mesenteric artery (SMA) ischaemic disease in vascular surgery.
Methods
The clinical data of 215 patients with SMA ischaemic disease (41 cases with Riolan’s arch and 174 cases without) admitted to the Department of Vascular Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University (China) from January 2019 to April 2023 were reviewed. Clinical characteristics, imaging findings, treatment, perioperative complications, and patient follow-up data were analysed to observe the impact of Riolan’s arch on the prognosis of patients with SMA ischaemic disease.
Results
There were significant differences in body mass index (Riolan’s arch group: 22.82 ± 3.28 vs 24.03 ± 4.26 in non-Riolan’s arch group, P = 0.049), Takayasu’s arteritis (4.9% vs 0, respectively, P = 0.036), and secondary intervention (3.3% vs 1.9%, respectively, P < 0.001) between the two groups. Propensity score matching was used to exclude the effect of baseline data on patient outcomes. There were significant differences related to therapy method (conservative treatment, Riolan’s arch group: 24.1% vs 39.7% in the non-Riolan’s arch group; operative treatment, Riolan’s arch group: 51.7% vs 20.7% in the non-Riolan’s arch group, P = 0.014), as well as in-hospital time (9.79 ± 4.20 vs 6.86 ± 4.32, respectively, P = 0.011). There was no statistically significant difference in Kaplan–Meier curves between the two groups (log-rank test P = 0.476).
Conclusions
Riolan’s arch plays an important compensatory role in SMA ischaemic disease, especially in chronic disease. We found significant differences in the treatment methods and length of hospital stay of Riolan’s arch, which may suggest that Riolan’s arch has some reference value in the choice of treatment mode.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, NO. 321 Zhongshan Road, Gulou District, Nanjing, Jiangsu Province, China.
- Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Vascular Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, NO. 321 Zhongshan Road, Gulou District, Nanjing, Jiangsu Province, China. qiaotongmail@nju.edu.cn.
Förderung
- National Natural Science Foundation of China
- Scientific research project of Jiangsu Provincial Department of Health
Zitieren
APA
Zhang, M., Maimaitiaili, S., Ji, R., Tang, C., Cai, J., Liu, Z., & Qiao, T. (2024). The value of treatment choice and clinical prognosis for Riolan’s arch in chronic superior mesenteric artery ischaemic disease. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-024-04691-y
Vancouver
Zhang M, Maimaitiaili S, Ji R, Tang C, Cai J, Liu Z, et al. The value of treatment choice and clinical prognosis for Riolan’s arch in chronic superior mesenteric artery ischaemic disease. International Journal of Colorectal Disease. 2024. doi:10.1007/s00384-024-04691-y
BibTeX
@article{Zhang2024,
author = {Zhang, Mengqiang and Maimaitiaili, Subinuer and Ji, Run and Tang, Chen and Cai, Jing and Liu, Zhao and Qiao, Tong},
title = {The value of treatment choice and clinical prognosis for Riolan’s arch in chronic superior mesenteric artery ischaemic disease},
journal = {International Journal of Colorectal Disease},
year = {2024},
doi = {10.1007/s00384-024-04691-y}
}
EUVIMED